Continuing to actively contribute to contain the spread of COVID-19 pandemic, Apple recently invested $10 million in COPAN Diagnostics to manufacture COVID-19 sample collection kits. Apple’s monetary financing in COPAN is part of its Advance Manufacturing Fund for U.S. businesses, which is intended to facilitate an increase in the production of coronavirus sample collections kits up to one million units per week by the end of July.
COPAN is a manufacturer of collection kits and global transportation of microbiology assays. The company is known for its advance quality and innovative solutions for collection and transportation of samples. Now, the investment will help the company in mass production of sample collection kits for coronavirus to aid health authorities in their efforts to test individuals and stop transmission of COVID-19.
Apple against COVID-19
Standing firm during this global health crisis, Apple is pro-actively contributing financially and digitally to halt the rate of transmission of coronavirus in the United States and worldwide. Apple has manufactured millions of face shields and donated N95 masks to frontline warriors.
For easy and quick screening at home, Apple built COVID-19 app and website exclusively for the United States. Users can answer a series of questions related to COVID-19 exposure, and get CDC approved suggestions to regarding symptoms. Apple also provided mobility data in 63 countries obtained via its Maps app, to help health authorities identify locations visited by large groups of people and take necessary precautionary steps. For its Maps app, the tech giant also opened a registration portal for health facilities to register their testing locations to be visible on the Map.
Apple also streamed One World: Together At Home virtual concert for Global Citizens to raise funds for COVID-19 pandemic victims.
Mostly importantly, Apple is also collaborating with Google to develop contact tracing technology. Initial API details were released last week for health authorities to build and test apps before the release of Bluetooth contact tracing technology.
Advance Manufacturing Fund
This $5 billion fund was setup to support manufacturing in the United States in the hope to create jobs. Since its establishment in 2017, Apple has invested in Finisar and Corning. Thus, $10 million monetary assistance in COPAN will not only promote domestic manufacturing but also help fight this spiraling COVID-19 pandemic.
We feel a deep sense of responsibility to do everything we can to help medical workers, patients, and communities support the global response to COVID-19,” said Jeff Williams, Apple’s chief operating officer. “COPAN is one of the world’s most innovative manufacturers of sample collection kits for COVID-19 testing, and we’re thrilled to partner with them so they can expand as we work to address this critical issue for our nation. I couldn’t be prouder of our teams for bringing all of their energy, passion, and innovative spirit to supporting the country’s COVID-19 response.- Jeff Williams, Apple COO
Read the complete press release here.
We have comprehensively covered Apple’s coronavirus efforts. Read more:
- iOS 13.5 Beta Released with COVID-19 Exposure Notifications for Contact Tracing
- Apple Manufactures Face Shields for healthcare providers
- Apple releases COVID-19 app and website screening tools
- Stanford Medical Teams builds an screening app with Apple for Frontline workers
- Google and Apple build contract tracing technology
- Apple launches Mobility Data trends tool to combat COVID-19 spread
- Apple opens registration portal for healthcare authorities to show testing locations on Maps app